期刊文献+

血管内皮功能障碍与高血压 被引量:28

Endothelial Dysfunction and Hypertension
下载PDF
导出
摘要 血管内皮功能障碍与高血压密切相关。一方面血管内皮功能障碍在高血压的发生、发展过程中起重要作用;另一方面高血压本身又加重血管内皮功能障碍,形成恶性循环。现综述血管内皮细胞的生理功能、血管内皮功能障碍的相关因素、血管内皮功能障碍与高血压关系、血管内皮功能检测及血管内皮功能障碍的修复等方面的研究进展。 The relationship between endothelial dysfunction and hypertension is a close one. On one hand, endothelial dysfunction may promote the occurrence and the development of hypertension. On the other hand, hypertension may induce endothelial dysfunction, and aggravate it. This article reviews the physiological function of vascular endothelial cells, the correlation factor of endothelial dysfunction, the relations of endothelial dysfunction with hypertension, the detection methods of the endothelial function, and the recovery of the endothelial dysfunction.
出处 《心血管病学进展》 CAS 2009年第1期62-65,共4页 Advances in Cardiovascular Diseases
关键词 血管内皮 内皮功能障碍 高血压 blood vessel endothelium endothelial dysfunction hypertension
  • 相关文献

参考文献4

二级参考文献49

  • 1向光大,曹红燕,曾尟枚,赵林双.1型糖尿病患者胰岛素治疗前后内皮依赖性血管舒张功能的变化[J].中国糖尿病杂志,2006,14(2):109-111. 被引量:5
  • 2Cooke J P,Arterioscler Thromb,1994年,14卷,653页
  • 3Simonet WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell, 1997, 89: 309-319.
  • 4Zhang J, Fu M, Myles D, et al. PDGF induces osteoprotegerin expression in vascular smooth muscle ceils by multiple signal pathways. FEBS letters, 2002, 521 : 180-184.
  • 5Jono S, Ikari Y, Shioi A, et al. Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease. Circulation, 2002, 106 : 1192-1194.
  • 6Schoppet M, Sattler AM, Schaefer JR, et al. Increased osteoprotegerin serum levels in men with coronary artery disease. J Clin Endocrinol Metab, 2003, 88: 1024-1028.
  • 7Knudsen ST, Foss CH, Poulsen PL, et al. Increased plasma concentrations of osteoprotegerin in type 2 diabetic patients with microvascular complications. Eur J Endocrinol, 2003, 149 : 39- 42.
  • 8Avignon A, Sultan A, Plot C, et al. Osteoprotegerin is associated with silent coronary artery disease in high-risk but asymptomatic type 2 diabetic patients. Diabetes Care, 2005, 28: 2176-2180.
  • 9Galluzzi F, Stagi S, Salti R, et al. Osteoprotegerin serum levels in children with type 1 diabetes: a potential modulating role in bone status. Eur J Endocrinol, 2005, 153 : 879-885.
  • 10Xiang GD, Wu YH. Apolipoprotein e4 allele and endotheliumdependent arterial dilation in type 2 diabetes mellitus without angiopathy. Diabetologia, 2003, 46: 514-519.

共引文献70

同被引文献397

引证文献28

二级引证文献166

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部